Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Infectious Disease Vaccines Market by Type (Brand) – Diphtheria, Tetanus and Pertussis (DTP) Combination Vaccines (Boostrix, Pediarix, Pentacel, Other, Herpes Zoster Vaccines (Zostavax, Shingrix, Other); Human Papilloma Virus Vaccines (Gardasil, Other); Influenza Vaccines (FluLaval, Fluzone, Other); Meningococcal Vaccines (Menveo, Bexsero, Menactra, Trumenba, Other); Pneumococcal Vaccines (Pneumovax, Synflorix, Prevnar/Prevnar 13, Other); Rotavirus Vaccines (Rotarix, RotaTeq, Other) and Forecast 2021-2027

$3,000.00

Report Specifications: Market Size, Share, Growth, Trends, Forecast, Geography

Vaccination against a range of bacterial and viral infectious diseases is an integral part of communicable disease control world-wide. The most common and serious vaccine-preventable diseases tracked by the World Health Organization (WHO) are: diphtheria, Haemophilus influenzae serotype b infection, hepatitis B, measles, meningitis, mumps, pertussis, poliomyelitis, rubella, tetanus, tuberculosis, and yellow fever. Vaccines are known to be the safest, most effective way to prevent infectious diseases, and they have enabled the worldwide eradication of many devastating diseases like polio and smallpox. New safe and effective vaccines against infectious diseases are developed by studying the interactions between invading pathogens and the human immune system. Early immunization of infants and completion of the full schedule of vaccinations up to and through adulthood contributes to reducing the incidence and burden of vaccine preventable diseases. Very high immunization coverage can lead to complete blocking of transmission for many vaccine preventable diseases (VPD). The worldwide eradication of smallpox and the near eradication of polio from many countries provide excellent examples of the role of immunization in disease control. DTP combination vaccines include vaccines against diphtheria, tetanus and pertussis (DTP) that also contain one or more components to provide protection against other infections, including hepatitis B, Haemophilus influenzae type B and/or polio. Meningococcal vaccines include meningococcal group A, C, W-135 and Y vaccines, meningococcal group B vaccines and meningococcal group C vaccines. Pentacel is a DTP, Haemophilus influenzae type B and polio vaccine. Pediarix is a DTP, hepatitis B and polio vaccine. Menactra and Menveo are meningococcal type A, C, W-135 and Y vaccines. Bexsero and Trumenba are meningococcal type B vaccines.

The global infectious disease vaccines market segmentation is based on type (brand) – Diphtheria, Tetanus and Pertussis (DTP) combination vaccines (Boostrix, Pediarix, Pentacel, other, herpes zoster vaccines (Zostavax, Shingrix, other); human papilloma virus vaccines (Gardasil, other); influenza vaccines (Flulaval, Fluzone, other); meningococcal vaccines (Menveo, Bexsero, Menactra, Trumenba, other); pneumococcal vaccines (Pneumovax, Synflorix, Prevnar/Prevnar 13, other); rotavirus vaccines (Rotarix, Rotateq, other).

The global infectious disease vaccines market report provides market size ($Million 2017 to 2027), market share, trends and forecast (CAGR%, 2021 to 2027). The global infectious disease vaccines market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global infectious disease vaccines market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent selected vaccine product licensing deals in the last two years in the global market.

Major players operating in the global infectious disease vaccines market and profiled in this report include Astellas Pharma, CSL Behring, Dynavax Technologies, Emergent BioSolutions, GlaxoSmithKline, Merck, Mitsubishi Tanabe Pharma, Novavax, Pfizer, and Sanofi.

DATA INCLUDED: Infectious Disease Vaccines Market Size, Infectious Disease Vaccines Market Share, Infectious Disease Vaccines Market Growth Rates, Infectious Disease Vaccines Market Trends, and Infectious Disease Vaccines Market Forecast to 2027

Market Data:

  • Global COVID-19 Impact Analysis
  • Base years for estimation: 2019 & 2020
  • Actual estimates/Historical data: 2017-2019
  • Forecast period: 2021-2027
  • Market representation: Revenue in $million and CAGR % from 2021 to 2027
  • Regional scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
  • Country scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE and others.
  • Report coverage: Revenue forecast, company share, competitive landscape, growth factors, and trends
  • 15% free customization scope: If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Qualitative Analysis:

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Key market opportunities
  • Market size
  • Growth trends
  • Porter’s five forces analysis
  • Market attractiveness analysis
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product portfolio
    • Strategic insights
    • Recent developments

Quantitative Analysis:

  • Market size estimates and forecast for all segments
  • Regional market size estimated and forecast for major countries
  • Company financial performance
  • Competitive landscape: Company market share analysis

Clear
Please contact us through the form below for additonal offers on individual reports.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation ($million, 2017-2027)
    • Forecast Estimation ($million and CAGR%, 2021-2027)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Key Questions Answered:
1. What are the factors driving and limiting this market, key success factors and challenges?
2. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?
3. How do markets perform between countries and regions?
4. What market segments are contributing to maximum share and greatest growth?
5. What are the product or procedure volumes by country and regions?

Actionable Insights Included:
1. Product portfolio matrix (Share vs. Growth)
2. Market attractiveness (Region vs. Growth)
3. Spot matrix (Product vs. Region)
4. Geographic distribution matrix (Share vs. Growth)

Infectious Disease Vaccines Market

1. Type (Brand)
1.1. DTP Combination Vaccines
1.1.1. Boostrix
1.1.2. Pediarix
1.1.3. Pentacel
1.1.4. Other
1.2. Herpes Zoster Vaccines
1.2.1. Zostavax
1.2.2. Shingrix
1.2.3. Other
1.3. Human Papilloma Virus Vaccines
1.3.1. Gardasil
1.3.2. Other
1.4. Influenza Vaccines
1.4.1. FluLaval
1.4.2. Fluzone
1.4.3. Other
1.5. Meningococcal Vaccines
1.5.1. Menveo
1.5.2. Bexsero
1.5.3. Menactra
1.5.4. Trumenba
1.5.5. Other
1.6. Pneumococcal Vaccines
1.6.1. Pneumovax
1.6.2. Synflorix
1.6.3. Prevnar/Prevnar 13
1.6.4. Other
1.7. Rotavirus Vaccines
1.7.1. Rotarix
1.7.2. RotaTeq
1.7.3. Other

2. Company Profiles
2.1. Astellas Pharma
2.2. CSL Behring
2.3. Dynavax Technologies
2.4. Emergent BioSolutions
2.5. GlaxoSmithKline
2.6. Merck
2.7. Mitsubishi Tanabe Pharma
2.8. Novavax
2.9. Pfizer
2.10. Sanofi

    Request ToC / Sample Report / Discount

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 463-5840
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]